IRD vs MRNA · rev $11.0M vs rev $1.94B
Opus Genetics, Inc. (IRD) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
IRD currently screens at market cap $35.7M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the IRD and MRNA stock pages for the full models.
Not investment advice.